Trial Profile
Pharmacokinetic Evaluation of an Intensified and Decreasing Dosing Regimen of Mycophenolate Sodium in Combination With Tacrolimus During the First 3 Months Post Kidney Transplant (the myFORTic Study).
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 Nov 2012
Price :
$35
*
At a glance
- Drugs Mycophenolate sodium (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- Acronyms myFORTic
- 01 May 2012 Status changed from completed to recruiting as reported by European Clinical Trials Database (EudraCT2008-006072-30).
- 01 May 2012 Status changed from completed to recruiting as reported by European Clinical Trials Database (EudraCT2008-006072-30).
- 26 Mar 2010 Actual end date added to 1 Mar 2010 as reported by ClinicalTrials.gov.